Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_____________

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  August 15, 2011


OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)

Florida
0-11102
59-1564329
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
I.R.S. Employer Identification No.)

4041 S.W. 47 Avenue, Fort Lauderdale, Florida       33314
(Address of principal executive offices)                    (Zip Code)

(954) 587-6280
Registrant’s telephone number, including area code:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On August 15, 2011, Edward Anchel resigned from the Board of Directors of Ocean Bio-Chem, Inc. (the “Company”).  There were no disagreements between Mr. Anchel and the Company on any matter relating to the Company's operations, policies or practices.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

August 16, 2011
  Ocean Bio-Chem, Inc.  
       
 
By:
/s/ Jeffrey S. Barocas  
    Jeffrey S. Barocas  
    Chief Financial Officer